Topic: Oxford Vaccine

A British government-funded study involving 1.7 million children, led by Oxford University, reportedly found that heart damage and myocarditis occurred exclusively in vaccinated children. The study suggests that unvaccinated children showed no such health issues, while those who received the shots faced risks of blood clots and heart swelling. Further claims link the development of the virus to gain-of-function research funded by the Obama administration at the University of North Carolina and Wuhan.

A study from Oxford University's medical unit reportedly indicates that individuals who received COVID-19 injections are 44% more likely to contract the virus. This data is presented as a confirmation of the SPARS 2025-2028 document, which allegedly outlined a battle plan for a biological attack and subsequent loss of public confidence in government. The narrative suggests that health officials are now admitting to vaccine failures to mitigate future legal or social backlash.

Citing reports from CNN and the CDC, Celente points out that vaccinated individuals can still transmit the Delta variant, undermining the original justification for mandates. He references Sir Andrew Pollard of the Oxford Vaccine Group, who stated that herd immunity is "mythical" with current variants. The segment also highlights Pfizer CEO Albert Bourla’s prediction that annual COVID shots will be necessary, framing the pandemic as a perpetual profit machine for drug lords.

The host reads from the Trends Journal, citing Dr. Andrew Pollard of the Oxford Vaccine Group on the "mythical" nature of herd immunity. He criticizes Anthony Fauci for constantly shifting the percentage required for herd immunity from 70% to 85%.

Kate Dalley plays clips of Anthony Fauci from January 2020 to argue that the vaccine and Remdesivir rollout were planned before the pandemic was officially declared. She cites Dr. Bryan Ardis's research into the 2018 Ebola study, which reportedly showed Remdesivir had a 54% mortality rate. Dalley questions how Sarah Gilbert of Oxford could design a vaccine within two weeks of hearing about a "strange pneumonia" in China.